For many cancer patients, treatment can make eating difficult and uncomfortable. Chef Gia Fazio joined us on 'The Nine' to ...

A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...

Oncologists said they worried their patients may delay or forgo effective therapies while turning to these unproven ...

(Nasdaq: CELC), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced updates to the Phase 3 ...

Common cancers, like breast, skin, and lung cancers, have become far more survivable in recent years, but not pancreatic cancer. That is changing, though, thanks to very recent breakthroughs. NPR's ...

The long scientific journey that led to the drug for pancreatic cancer is a triumph of both public and private research ...

Preliminary findings were presented at the 2025 ASCO Genitourinary Cancers Symposium. 2 Investigators reported that 71% of ...

​Daraxonrasib is a once-daily oral pill that demonstrated statistically significant and clinically meaningful improvements in ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg ...

Polycystic ovarian syndrome (PCOS) will now be known as polyendocrine metabolic ovarian syndrome (PMOS), the most significant ...